Drug Shortage Report for JAMP-BEZAFIBRATE SR
| Report ID | 234532 |
| Drug Identification Number | 02453312 |
| Brand name | JAMP-BEZAFIBRATE SR |
| Common or Proper name | Bezafibrate Sustained Release Tablets |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | BEZAFIBRATE |
| Strength(s) | 400MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 30 |
| ATC code | C10AB |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-08-02 |
| Estimated end date | Unknown |
| Actual end date | 2024-09-20 |
| Shortage status | Resolved |
| Updated date | 2024-09-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2024-09-21 | English | Compare |
| v6 | 2024-09-20 | French | Compare |
| v5 | 2024-09-20 | English | Compare |
| v4 | 2024-09-20 | French | Compare |
| v3 | 2024-09-20 | English | Compare |
| v2 | 2024-08-05 | French | Compare |
| v1 | 2024-08-05 | English | Compare |
Showing 1 to 7 of 7